Department of Virology, Armed Forces Research Institute of Medical Research, Bangkok, Thailand.
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S36-9. doi: 10.1016/j.ijantimicag.2010.06.019. Epub 2010 Aug 8.
Dengue virus is the most common arboviral infection of humans in the tropical and subtropical regions of the world. This review briefly describes some of the challenges it presents. Dengue is an emerging disease; it is increasing in geographical distribution and severity, despite being significantly underreported. The World Health Organization case definition for the generally more severe manifestation of infection, dengue haemorrhagic fever (DHF), is controversial. The name DHF is something of a misnomer as the disease infrequently results in frank haemorrhage; the hallmark of DHF is actually plasma leakage. The existence of four closely related dengue virus serotypes contributes to difficulties in diagnosis and to original antigenic sin in the serological response to infection. The existence of multiple serotypes can result in more severe disease upon a second infection and complicates vaccine development. Nevertheless, a safe and effective vaccine is the greatest prospect for stemming the tide of dengue.
登革热病毒是世界热带和亚热带地区最常见的人类虫媒病毒感染。本文简要描述了它带来的一些挑战。登革热是一种新出现的疾病;尽管报告严重不足,但它的地理分布和严重程度都在增加。世界卫生组织对一般更为严重的感染表现,即登革出血热(DHF)的病例定义存在争议。DHF 的名称有些用词不当,因为该疾病很少导致明显出血;DHF 的标志实际上是血浆渗漏。四种密切相关的登革热病毒血清型的存在导致诊断困难,并导致感染血清学反应中的原始抗原性错误。在第二次感染时,存在多种血清型可能导致更严重的疾病,并使疫苗开发复杂化。然而,安全有效的疫苗是遏制登革热浪潮的最大希望。